However, no such effect is observed when the expression of PD-L1 is blocked in APC, indicating that PD-1 is more dominant than PD-L1 in promoting lymphocyte apoptosis and inhibiting proliferation in MS (Trabattoni et al., 2009). Here, PDCD1 is linked to myeloid sarcoma.